You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 235 Preclinical evaluation and anti-tumor activity of AZD6422, a CLDN18.2 targeting armored CAR-T for gastric, esophageal and pancreatic cancers

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
235 Preclinical evaluation and anti-tumor activity of AZD6422, a CLDN18.2 targeting armored CAR-T for gastric, esophageal and pancreatic cancers

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023338040
Dec 202385012
Jan 202466010
Feb 20243605
Mar 20247607
Apr 202498013
May 2024128011
Jun 202494014
Jul 2024141015
Aug 202411405
Sep 2024120018
Oct 2024119023
Nov 202464021
Dec 202464025
Jan 202562017
Feb 20251108
Mar 2025006
Apr 2025002
May 2025204
Jun 2025003
Total16180259